Retour
Fourchette du Jour
1,79 €
2,04 €
Fourchette 52 Semaines
0,57 €
2,73 €
Volume
17 353 935
Moyenne 50J / 200J
1,72 €
/
1,37 €
Clôture Précédente
2,10 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,3 | 0,3 |
| P/B | — | 2,9 |
| ROE % | -776,9 | 3,7 |
| Net Margin % | -1537,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
5,00 €
+160.4%
Low: 3,50 €
High: 6,00 €
BPA Prévisionnel
-0,22 €
CA Est.
1,7 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,61 €
0,50 € – 3,25 €
|
1 B | 2 |
| FY2029 |
0,65 €
0,20 € – 1,31 €
|
500 M | 2 |
| FY2028 |
0,02 €
-0,40 € – 0,83 €
|
170 M | 4 |
Insider Trading Activity
7 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 |
Ramachandran Ramesh
Chief Accounting Officer
|
grant | 518 250 | — | — |
| Jan 2, 2026 |
Musunuri Shankar
Chief Executive Officer
|
grant | 6 246 402 | — | — |
| Jun 5, 2025 |
Chandrasekhar Satishchandran
Director
|
grant | 151 316 | — | — |
| Jun 5, 2025 |
Castillo Kirsten
Director
|
grant | 151 316 | — | — |
| Jun 5, 2025 |
Kompella Uday
Director
|
grant | 151 316 | — | — |
| Jun 5, 2025 |
Coleman Blaise
Director
|
grant | 151 316 | — | — |
| Jun 5, 2025 |
Zhang Junge
Director
|
grant | 151 316 | — | — |
Points Clés
Negative free cash flow of -57,15M
Capital efficient — spends only 4,19% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)8,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-776,89%
ROIC-224,94%
Net Margin-1537,41%
Op. Margin-1425,70%
Sécurité
Debt / Equity
N/A
Current Ratio1,06
Interest Coverage-12,13
Valorisation
P/E Ratio
-9,28
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,83% | Revenue Growth (3Y) | -14,49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,41M | Net Income (TTM) | -67,85M |
| ROE | -776,89% | ROA | -155,91% |
| Gross Margin | 45,86% | Operating Margin | -1425,70% |
| Net Margin | -1537,41% | Free Cash Flow (TTM) | -57,15M |
| ROIC | -224,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,06 |
| Interest Coverage | -12,13 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,28 | P/B Ratio | N/A |
| P/S Ratio | 142,66 | PEG Ratio | -0,40 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 629,56M | Enterprise Value | 644,14M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,41M | 4,06M | 6,04M | 2,49M | 0,0 |
| Net Income | -67,85M | -54,05M | -63,08M | -86,80M | -58,37M |
| EPS (Diluted) | -0,23 | -0,20 | -0,26 | -0,40 | -0,30 |
| Gross Profit | 2,02M | 2,09M | 5,33M | 2,49M | 0,0 |
| Operating Income | -62,92M | -54,76M | -65,53M | -89,07M | -58,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 43,52M | 82,44M | 64,55M | 108,63M | 105,76M |
| Total Liabilities | 56,46M | 52,81M | 23,98M | 34,65M | 9,94M |
| Shareholders' Equity | -12,17M | 29,63M | 40,56M | 73,98M | 95,82M |
| Total Debt | 33,14M | 32,50M | 6,94M | 6,37M | 3,31M |
| Cash & Equivalents | 18,57M | 58,51M | 39,46M | 77,56M | 94,96M |
| Current Assets | 24,34M | 61,68M | 42,97M | 98,49M | 102,65M |
| Current Liabilities | 23,04M | 21,59M | 17,09M | 28,53M | 7,00M |